2018 / 06

Next Paper
DOI: 10.24075/brsmu.2018.094

OPINION

The use of monoclonal antibodies in autoimmunity treatment

Merzlyak EM1,2, Syrko DS2, Musatkina EA2, Israelson MA1,2
About authors

1 Group of structural Organization of T-cell Immunity, Department of Adaptive Immunity Genomics, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow

2 Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow

Correspondence should be addressed: Ekaterina M. Merzlyak
Miklouho-Maclay 16/10, Moscow, 117997; ur.liam@99niretake

About paper

Funding: this work was supported by the Ministry of Science and Higher Education of the Russian Federation (ID RFMEFI60716X0158).

Received: 2018-12-06 Accepted: 2018-12-27 Published online: 2019-01-01
|
Figure. Monoclonal antibody treatment approaches for autoimmune disorders